GLENN HUMPHRESS: Open Payments
NPI 1366635666 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 18 payments from 9 companies in 2025. Trend: 2023 $1,130 · 2024 $471 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| Alkermes, Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Tris Pharma Inc | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Neos Therapeutics, LP | 1 | $19 |
| Bausch Health US, LLC | 1 | $17 |
Products named: REXULTI, LYBALVI, VRAYLAR, Auvelity, Dyanavel XR, INGREZZA, CAPLYTA, Cotempla XR-ODT.
Industry payments across TX — which companies pay providers there.
